
Founded
1997
29 years
Employees
501-1000
Annual Revenue
Not Disclosed
(2026)
Products
1
Saama Technologies is a Campbell, California-headquartered clinical AI and analytics platform vendor focused on life sciences. Its pharmacovigilance footprint is delivered via Active Safety Analytics for Pharma (ASAP), an analytics engine co-built with Gilead Sciences (launched 2020-10-26) with scientific advice from the Reagan-Udall Foundation for the FDA. ASAP applies the FDA Sentinel Common Data Model and the TreeScan signal-detection methodology over real-world data (claims and EMR) covering, vendor-reported, longitudinal data on 150M+ patients across 15+ years.
Saama also markets an Agentic AI Framework (announced 2025-09-29) hosting modular Clinical AI Agents under "partial autonomy" with human-in-the-loop oversight, with a proprietary "Clinical-LM" LLM as foundation. Other platform products: Data Hub, Smart Data Quality (SDQ), Operational Insights, Patient Insights, AI-Powered Document Generator (DocGenAI), and the BRAIN family (SCE/SDTM/Visualization/Consortium). The platform was historically branded Life Science Analytics Cloud (LSAC).
ASAP is a signal-detection and real-world-data analytics overlay, not a traditional ICSR case-processing system.
Saama is exclusively life-sciences-focused. Vendor-reported scale (dating to 2020): "over 50 biotech companies… on more than 1,500 studies, including many of the top 20 pharmaceutical companies." Named, verifiable customers: Pfizer (multi-year, expanded Feb 2024); AstraZeneca (multi-year Oct 2023); Gilead Sciences (ASAP co-builder); Taiho Oncology (mid-cap oncology). Reagan-Udall Foundation for the FDA is a scientific-advice collaborator on ASAP. Customer segmentation: Big Pharma is well represented; biotech/CDMO/generic/medical device customers are not specifically named in public press. ASAP is positioned for PV/epidemiology/medical-affairs leaders who already run a primary safety case-processing system, as an active-surveillance overlay on RWD.
Industries Served
Saama is privately held. Revenue and total funding are undisclosed. Reported investors, per a lower-confidence third-party profile: Carlyle, Amgen Ventures, Merck GHIF, Pfizer Ventures, McKesson Ventures. Multi-year enterprise agreements: Pfizer (initial 2020, expanded Feb 2024 across global R&D portfolio); AstraZeneca (Oct 2023 for SDQ, Data Hub, Patient Insights). Dollar values are undisclosed; both imply $1M+ enterprise deal sizes for top-20 pharma. Astraa was spun off as a non-life-sciences cross-vertical business.
Browse all software products offered by Saama Technologies, Inc..
Current platform menu (2026-05-14): Data Hub, Smart Data Quality (SDQ), Operational Insights, Patient Insights, AI-Powered Document Generator (DocGenAI), BRAIN / BRAIN SCE / BRAIN SDTM / BRAIN Visualization. PV-specific product: Active Safety Analytics for Pharma (ASAP) — Sentinel CDM ingestion, TreeScan signal detection, workflow for signal assessment and medical review, Datavant token integration for joining claims/EMR/clinical datasets.
Agentic AI Framework (Sep 2025) hosts modular Clinical AI Agents for patient narrative generation, inclusion/exclusion criteria drafting, data review, anomaly detection, task resolution; underpinned by proprietary Clinical-LM. DocGenAI uses a "Decision by Jury" multi-LLM consensus approach with reported 20–40% error reduction and 30% drafting-time reduction (vendor reports). TLF Analyzer with Figures-to-Text (Oct 2025) interprets Kaplan–Meier, forest, waterfall, and box plots into clinical narrative text.
Not present in ASAP: ICSR E2B R2/R3 import/export, MedDRA/WHODrug coding workflows, aggregate reporting (PSUR/PBRER, DSUR, PADER), regulatory gateway submissions (FDA ESG, EudraVigilance, PMDA), case intake from paper/email/call-center/web-form. Saama is not a system-of-record safety database.
Hosted on AWS infrastructure; Saama Platform Enterprise listed on AWS Marketplace ("Private Offers Only"). Datavant partnership for HIPAA-compliant patient tokens joining claims/EMR/clinical datasets. Reagan-Udall Foundation for the FDA collaborator on ASAP. Multi-year Pfizer (initial 2020, expanded 2024) and AstraZeneca (2023) partnerships. Gilead Sciences co-built ASAP. Industry alignment: ISO/IEC 27001:2013, 21 CFR Part 11, ICH E6 ("program is aligned to" — vendor reports, not third-party attestation).
Cloud Partners
Technology Partners
Saama markets discrete service lines: Bespoke LLM Tuning, LLM Operations, Prompt Engineering, Platform Architecture & Strategy, Use Case Identification, RAG accelerator, PII Scrubber, and Generative Reporting. Vendor reports configuration "in a few days to weeks" rather than months. Customer-side validation effort is not publicly benchmarked. AWS Marketplace G2-sourced commentary mentions resource-availability constraints during ramp-up.
Analyst recognition: Leader in Everest Group Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix Assessment 2024 — second consecutive year; 18 providers assessed. AI Breakthrough "Best AI-Based Life Sciences Solution" 2024 and 2025 (vendor reports second consecutive year). BioTech Breakthrough Awards 2022 "Analytics Solution Provider of the Year." No current Gartner Magic Quadrant placement (Gartner does not cover the clinical D&A platforms space cleanly); no Forrester Wave placement; no IDC MarketScape placement.
Trust page references ISO/IEC 27001:2013 alignment, 21 CFR Part 11 alignment, ICH E6 alignment — vendor-stated program alignment, not third-party attestation. SOC 2 Type II report is not referenced on the public Trust page. ASAP is described in press as "the first validated pharmacovigilance solution to leverage the FDA Sentinel Common Data Model" (vendor reports).
Saama maintains an active press cadence around AI/ML feature launches (DQ Co-pilot Sept 2023; GenAI Chat / Interactive Review Listings Jan 2024; TLF Analyzer Oct 2025; Agentic AI Framework Sep 2025) and Big Pharma agreement expansions (Pfizer Feb 2024). Independent review-platform coverage is sparse: G2 listing shows 4.0/5.0 across 2 reviews under "Scientific Data Management Systems (SDMS)" with "Agentic AI – SDMS" sub-feature set; no active Capterra or Gartner Peer Insights listing.
Headquarters
Campbell, California, United States
Founded
1997 (29 years in business)
Company Size
501-1000 employees
Type
Private
Owned by Not applicable - independent company
Annual Revenue
Not Disclosed (2026)